GRFS Grifols SA ADRs

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SM:GRF.P .

$15.41  -0.59 (-3.69%)
As of 03/04/2021 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Mid cap
Health Care
Drug Manufacturers—General
Spain
Spain
06/02/2011
261,425,000
819,771
$4,182,800,000
2.88%
SEC Edgar Online
20-F
398438408
US3984384087
B8K7T65

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
26.36
4.50
0.64
13.88%
13.13%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy